• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic.

作者信息

Guarnera Luca, Buzzatti Elisa, Bonanni Fabrizio, Paterno Giovangiacinto, Riccitelli Antonella, Forte Vittorio, Venditti Adriano, Del Principe Maria Ilaria

机构信息

Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

出版信息

Ann Hematol. 2023 Jun;102(6):1607-1608. doi: 10.1007/s00277-023-05184-8. Epub 2023 Mar 25.

DOI:10.1007/s00277-023-05184-8
PMID:36966239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10039765/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d64/10039765/be0e5bbd9f2f/277_2023_5184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d64/10039765/be0e5bbd9f2f/277_2023_5184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d64/10039765/be0e5bbd9f2f/277_2023_5184_Fig1_HTML.jpg

相似文献

1
Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic.新冠疫情期间直接口服抗凝剂用于内脏静脉血栓形成二级预防的真实世界经验
Ann Hematol. 2023 Jun;102(6):1607-1608. doi: 10.1007/s00277-023-05184-8. Epub 2023 Mar 25.
2
Treatment with direct oral anticoagulants (DOACs) and secondary prophylaxis in patients affected by multiple episodes of superficial venous thrombosis.直接口服抗凝剂（DOACs）治疗及对多发性浅静脉血栓形成患者的二级预防。
Eur J Intern Med. 2024 Apr;122:135-138. doi: 10.1016/j.ejim.2024.01.017. Epub 2024 Jan 19.
3
Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.内脏静脉血栓形成二级预防的长期抗凝治疗结果
Eur J Clin Invest. 2021 Jan;51(1):e13356. doi: 10.1111/eci.13356. Epub 2020 Aug 11.
4
Anticoagulation for COVID-19 Patients: A Bird's-Eye View.COVID-19 患者的抗凝治疗：鸟瞰。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211039288. doi: 10.1177/10760296211039288.
5
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience.新冠肺炎患者使用磺达肝素钠：一项初步的多中心真实世界经验。
J Cardiovasc Pharmacol. 2020 Oct;76(4):369-371. doi: 10.1097/FJC.0000000000000893.
6
Chemoprophylaxis for Venous Thromboembolism Prevention: Has the Horse Already Left the Barn?静脉血栓栓塞预防的化学预防：马是否已经跑了？
Plast Reconstr Surg. 2015 Oct;136(4):575e-577e. doi: 10.1097/PRS.0000000000001586.
7
Prevention of venous thromboembolism in hospitalized patients with inflammatory bowel disease.炎症性肠病住院患者的静脉血栓栓塞预防。
Inflamm Bowel Dis. 2013 Mar;19(3):669-71. doi: 10.1097/MIB.0b013e31827e7a0f.
8
Deep venous thrombosis and venous thromboembolism prophylaxis.深静脉血栓形成与静脉血栓栓塞的预防
Surg Clin North Am. 2015 Apr;95(2):285-300. doi: 10.1016/j.suc.2014.11.005.
9
Recurrent venous thromboembolism: quite harmless after all?复发性静脉血栓栓塞症：终究危害不大？
Thromb Haemost. 2008 Apr;99(4):655-6. doi: 10.1160/TH08-03-0137.
10
Real-time collection of data on patients with COVID-19 and thrombosis and/or haemorrhage has aided the development of thromboembolism prophylaxis guidelines at the Royal Surrey County Hospital during the COVID-19 pandemic.在新冠疫情期间，对新冠病毒感染合并血栓形成和/或出血患者的数据进行实时收集，有助于英国皇家萨里郡医院制定血栓栓塞预防指南。
Clin Med (Lond). 2021 Mar;21(Suppl 2):51-52. doi: 10.7861/clinmed.21-2-s51.

本文引用的文献

1
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.利伐沙班治疗非肝硬化性内脏静脉血栓形成：一项介入前瞻性队列研究。
Blood Adv. 2022 Jun 28;6(12):3569-3578. doi: 10.1182/bloodadvances.2022007397.
2
Direct oral anticoagulants for unusual-site venous thromboembolism.用于非常见部位静脉血栓栓塞的直接口服抗凝剂。
Res Pract Thromb Haemost. 2021 Jan 28;5(2):265-277. doi: 10.1002/rth2.12480. eCollection 2021 Feb.
3
Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
内脏静脉血栓形成二级预防的长期抗凝治疗结果
Eur J Clin Invest. 2021 Jan;51(1):e13356. doi: 10.1111/eci.13356. Epub 2020 Aug 11.
4
Evaluation of direct oral anticoagulants and vitamin K antagonists in mesenteric venous thrombosis.直接口服抗凝剂与维生素K拮抗剂在肠系膜静脉血栓形成中的评估
Phlebology. 2019 Apr;34(3):171-178. doi: 10.1177/0268355518779517. Epub 2018 May 31.
5
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.内脏静脉血栓形成的长期临床结局：国际登记处的结果。
JAMA Intern Med. 2015 Sep;175(9):1474-80. doi: 10.1001/jamainternmed.2015.3184.